A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses

We previously identified human phosphatidylethanolamine-binding protein 4 (hPEBP4) as an antiapoptotic protein with increased expression levels in breast, ovarian and prostate cancer cells, but low expression levels in normal tissues, which makes hPEBP4 an attractive target for immunotherapy. Here,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Mol Immunol
Main Authors: Sun, Weihong, Shi, Junyi, Wu, Jian, Zhang, Junchu, Chen, Huabiao, Li, Yuanyuan, Liu, Shuxun, Wu, Yanfeng, Tian, Zhigang, Cao, Xuetao, Li, Nan
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6141579/
https://ncbi.nlm.nih.gov/pubmed/29375131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cmi.2017.155
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados